DUBLIN, Feb. 3, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/j52q6k/blood_glucose) has announced the addition of the "Blood Glucose Testing and Diabetes Management" report to their offering.
The report has made a survey of selected companies marketing, manufacturing or developing various blood glucose testing and diabetes management supplies throughout the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included.
There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe.
Once thought of as primarily a childhood disease - sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes - the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes, particularly Type 2 diabetes, among adults across the world. As such, the global market for blood glucose testing products is undergoing a significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, certain segments of the market, such as home testing devices for diabetes management, will exhibit strong growth.
What's more, non-invasive testing now represents a major new area for the application of IVD testing. Additionally, direct access testing - or over-the-counter testing, which allows consumers to order tests themselves without visiting a doctor - has emerged as a strong force in the blood glucose testing segment. The purpose of this report is to describe the specific market segments for blood glucose testing and diabetes management. This study reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum or plasma or whole-blood glucose concentrations. Moreover, it examines clinical measurement devices, reagents and supplies as utilized in hospitals, clinics, doctor's offices and at-home care locations.
Key Topics Covered:
1. Overview
2. Diabetes 2.1 Demographics of Diabetes 2.2 Understanding the Metabolic Conditions Underlying and Associated with Diabetes 2.3 Economics of Diabetes
3. Market Analysis: Size, Growth, Share and Competitors
3.1 Worldwide Glucose Testing Market
3.2 U.S. Market
3.3 European Market
3.4 Asian Market
3.5 Competitive Situation
3.6 Market Drivers and Restraints
3.7 Market and Product Trends
3.8 Strategic Recommendations
3.9 Competitive Strategies
3.10 New Opportunities in the Professional Blood Glucose Meter Market
3.11 Adjacent Markets
4. Glucose Diagnostic and Monitoring Recommendations 4.1 Diagnosis of Diabetes Mellitus 4.2 Tight Glucose Control in Treating Diabetes 4.3 Recommendations for Glucose Control in Diabetic Patients 4.4 Hypoglycemia and Treatment
5. Glucose Testing Technology Platforms and Consumable Products
5.1 Types of Glucose Determination Technologies
5.2 Enzymatic Reactions Used to Determine Glucose Concentrations
5.3 Development of Blood Glucose Monitors: A Historical Evaluation
5.4 Accuracy and Precision in Glucose Meters
5.5 Key Issues for Glucose Testing Devices
5.6 Limitations of Existing Glucose Testing
5.7 Potential Areas of Improvement in Blood Glucose Meter Performance
5.8 Blood Glucose Reagent Test Strips
5.9 Comparison of Hand-Held Blood Glucose Meters with Clinical Laboratory Glucose Measurements
5.10 Continuous Glucose Monitoring Technology
5.11 Summary of Technologies Being Explored for Non-invasive Glucose Monitoring
5.12 A1c Monitoring Technology
5.13 Fructosamine Test
5.14 Related Reagents and Equipment
6. Glucose Testing Devices on the Market 6.1 Hand-Held Blood Glucose Meters and Strips for Self-testing 6.2 Point of Care Blood Glucose Meters for Professional Use 6.3 Clinical Blood Chemistry Analyzers 6.4 Continuous Glucose Patient Monitoring Systems 6.5 Non-Invasive Glucose Patient Monitoring Systems 6.6 A1c Testing 6.7 New Product Launches 6.8 Blood Glucose Meters, CGMs, and Data Management Software in Development 6.9 Recent Industry Activity 6.10 M&A Activity
7. Business Trends in Glucose Testing
7.1 Drivers of Clinical Glucose Testing
7.2 Competition for Professional POC Glucose Testing
7.3 Healthcare Cost Controls
7.4 Changes in Patient Management
7.5 Regionalization of Laboratory Care
7.6 Satellite Facilities
7.7 Professional Point-of-Care Testing
7.8 Factors Affecting OTC Medical Product Distribution
7.9 Drug Stores Critical to the Diabetic Care Category
7.10 Drivers of OTC and Self-Testing Markets
7.11 Cost Elements of Glucose Self-Testing
7.12 Costs of Doing Business in Europe
7.13 Drivers of European Diagnostics Testing
7.14 Cost Containment in Europe
7.15 Blood Glucose Self-Testing Insurance Coverage and Reimbursement
7.15.1 American OTC Testing and Self-Testing Reimbursement
7.15.2 European Reimbursement
7.16 Reimbursement Challenges
7.16.1 New Medicare Part B
7.17 Managed Care
7.18 Government Regulation of Medical Devices
7.19 Clinical Laboratory Improvement Act (CLIA)
7.20 FDA Labeling Requirements
7.21 Legal Liability for Glucose Meters
7.22 FDA's Artificial Pancreas Guidance Document
8. Technology Trends 8.1 Improving Today's Over-The-Counter (OTC) Blood Glucose Meters 8.2 Biosensor Technology 8.3 Artificial Pancreas 8.4 Telemedicine 8.5 Non-Traditional Methods for Sample Collection 8.6 Data Management
Companies Mentioned
- A. Menarini Diagnostics - 9.2 Abaxis, Inc. - Abbott Laboratories - ACON Laboratories - AgaMatrix - Alere - All Medicus - AMS Alliance - Apex Biotechnology Corporation - ARKRAY USA - Bayer - B. Braun Melsungen - Beckman Coulter - Bionime - Bio-Rad Laboratories, Inc. - Cambridge Sensors - Cardiocom - DexCom - Diagnostic Devices/Prodigy Diabetes Care - DiaSys - Diatron - Echo Therapeutics - Entra Health Systems - Fora Care - FIFTY50 Medical, Inc. - Genesis Health Technologies - GenExel-Sein - GlucoPlus - GlySens - Hainice Medical - HemoCue (a Quest Diagnostics company) - Home Diagnostics - Infopia - IN4 Technology - Integrity Applications - International Techidyne Corporation (ITC) - Instrumentation Laboratory Company - i-Sens - Jant Pharmacal - Johnson & Johnson - LabStyle Innovations Corporation - LifeHealth, LLC - Medtronic - Miraculins - Nipro Diagnostics - Nova Biomedical - Polymer Technology Systems - Prodigy Diabetes Care, LLC (formerly Diagnostic Devices, Inc.) - Radiometer Medical - Roche Diagnostics - Senseonics - 77 Elektronika Kft. - Siemens AG - Smiths Group - TaiDoc Technology - Techno Medica Co., Ltd. - Telcare - Tokyo Boeki Medisys - US Diagnostics - Ypsomed Holding - YSI Life Sciences
For more information visit http://www.researchandmarkets.com/research/j52q6k/blood_glucose
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article